Brown University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Brown University sits in the top decile of US sponsors by registered trial count (#141 of 15,742 sponsors by registered trial count).
Brown University: 231 sponsored US clinical trials, 34 recruiting.
Brown University sponsors 231 registered US clinical trials on ClinicalTrials.gov, 34 of them currently recruiting, and 156 completed. 6 of these trials are in Phase 3-4 (later-stage) and 89 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Alcohol Drinking, with 8 trials.
Top-decile sponsor footprint
Brown University ranks in the top decile of sponsors by registered trial count (#141 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
156 of 179 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (87.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
231 total, page 3 of 5
Treatments for Improving Mood in Depressed Teens-3
NCT03831360
Impact of Nicotine Reduction on Adolescent Cigarette Use, Alternative Tobacco Use, and Harm From Tobacco
NCT03860077
Beta Events and Sensory Perception
NCT04062318
Targeting Worry to Improve Sleep
NCT03684057
Bringing Awareness Into Eating
NCT04021745
A Study of Abemaciclib in Combination With Sunitinib in Metastatic Renal Cell Carcinoma
NCT03905889
Music & MEmory: A Pragmatic TRial for Nursing Home Residents With ALzheimer's Disease_part1
NCT03821844
Project MIMIC (Maximizing Implementation of Motivational Incentives in Clinics)
NCT03931174
Treatments for Improving Mood in Depressed Teens-2
NCT03831347
eTest: Real-time, Remote Monitoring System for Home-based HIV Testing Among High-risk Men Who Have Sex With Men
NCT03654690
Project CARE: An Integrated Treatment Adherence Program for Bipolar Disorder at the Time of Prison Release - Open Trial
NCT03825640
Safety Planning in Juvenile Justice for Suicidal Youth
NCT03655470
Substance Use Interventions for Truant Adolescents
NCT03655574
UH3 Phase - Mindfulness-Based Blood Pressure Reduction (MB-BP) : Stage 2a RCT
NCT03859076
BrUOG 355: Nivolumab to Tailored Radiation Therapy With Concomitant Cisplatin in the Treatment of Patients With Cervical Cancer
NCT03527264
Positive Psychology for Physical Activity Promotion
NCT03826173
Behavioral Economic Analysis of Demand for Marijuana
NCT03518567
Alcohol and Immune Response
NCT03483389
Text-based Alcohol Prevention for First Year College Students
NCT03864237
Psychosis Screening in Juvenile Justice
NCT03583073
Evaluating New Nicotine Standards for Cigarettes - Project 3
NCT03194256
Using Honest Placebos to Improve Pain Management in Hand Surgery Patients
NCT03631251
Web-based Physical Activity Intervention for Latinas
NCT03491592
BrUOG 337: Olaparib Prior to Radical Prostatectomy For Advanced Prostate Cancer Defects in DNA Repair Genes
NCT03432897
Targeted Pharmacological and Behavioral Treatments for Smoking in Schizophrenia Study 1
NCT03507127
Personal Values and Mandated Students
NCT03247647
Incentives to Promote Smoking Cessation in Low SES Women
NCT03173274
BrUOG 329 Onivyde & Metronomic Temozolomide in Recurrent Glioblastoma
NCT03119064
Brief Electronic Intervention for Heavy Drinking and Sex Risk Among MSM Seeking HIV Testing
NCT03435783
Computer-Assisted Brief Intervention
NCT03107117
Mindfulness-Based Blood Pressure Reduction: Stage 2a RCT
NCT03256890
Rapid Self-Testing to Prevent Fentanyl Overdose Among Young People Who Use Drugs
NCT03373825
Development and Pilot Testing of a Multimodal Web-based Program to Address Heavy Drinking During Smoking Cessation
NCT03068611
Vincristine Sulfate Liposome Injection (Marqibo®), Bendamustine and Rituximab-Phase I Trial in Indolent B-cell Lymphoma
NCT02257242
Optimizing PrEP Uptake & Adherence Among Male Sex Workers (MSW) Using a 2-stage Randomization Design
NCT03086057
Pepped on Pre-exposure Prophylaxis (PrEP): A Counseling and Problem-Solving PrEP Adherence Intervention for Stimulant Using Men Who Have Sex With Men (MSM).
NCT03137342
Adolescents With Substance Use Disorders Transitioníng From Residential Treatment to the Community
NCT03592186
Acute Neuroimmune Effects of Alcohol Using Free Water Imaging
NCT03370783
Marijuana's Impact on Alcohol Motivation and Consumption
NCT02983773
Neoadjuvant Therapy in Clinical Stage I-III HER2-positive Breast Cancer.
NCT02789657
Evaluation of Very Low Nicotine Content Cigarettes in Adolescent Smokers
NCT02587312
Project 3, Study 2: Extended Exposure to Low Nicotine Content Cigarettes in People With Current Affective Disorders
NCT02232737
Mechanisms of Mindfulness for Smoking Cessation
NCT02943499
Retention in PrEP Care for African American MSM in Mississippi
NCT03256435
Mindfulness-Based College: Stage 1
NCT03124446
Positive Psychotherapy for Smoking Cessation Enhanced With Text Messaging: A Randomized Controlled Trial
NCT02997657
Behavioral Interventions to Reduce Heavy Drinking Among MSM in HIV Primary Care
NCT02709759
FOLFOX-A For Locally Advanced Pancreatic Cancer: A Phase II Brown University Oncology Research Group Trial
NCT02578732
Evaluating a Real-Time, Remote Monitoring System for Home-Based HIV Testing
NCT02876926
A Comparison of Exercise Beliefs to Same-day Exercise Behavior
NCT03415542
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 32 |
| Phase 2 | 57 |
| Phase 3 | 4 |
| Phase 4 | 2 |
Therapeutic Areas
What is open in the Brown University pipeline
34 recruiting of 231 indexed (15% open); 156 completed (68%).
Phase mix: 6 late (III/IV) vs 89 early (I/II) (early-phase heavy).
Top condition: Alcohol Drinking (8 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Brown University: open-pipeline peers nationwide
Peers matched on 231 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
Brown University sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 231 trials (± recruiting share)
- University Hospitals Cleveland Medical Center · 230 trials · 18% recruiting
- Henry Ford Health System · 234 trials · 18% recruiting
- University of Iowa · 228 trials · 12% recruiting
- Georgetown University · 227 trials · 15% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Amicus Therapeutics · 15% recruiting · 34 trials
- Loma Linda University · 15% recruiting · 237 trials
- University of Rochester · 15% recruiting · 636 trials
- United States Naval Medical Center, San Diego · 15% recruiting · 41 trials
Related
What to do with this Brown University page
231 registered trials is a research-attention snapshot, not an endorsement of Brown University or any single study.
- 34 of Brown University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Alcohol Drinking is the condition Brown University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Alcohol Drinking trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Brown University pipeline card: 231 registered trials from official public datasets.Report a data error.